Plavix is used to prevent clotting in some heart patients. The price of the widely used blood thinner should drop once the patent ends on Thursday making it considerably more affordable.
Experts say the high cost of Plavix has contributed to patients not filling initial prescriptions for the drug or prematurely discontinuing the use of it.
Doctors say patients who stop taking the drug early could face catastrophic consequences including fatal cardiovascular events and strokes.
